RT Journal Article
SR Electronic
T1 Estimating the COVID-19 Prevalence in Spain with Indirect Reporting via Open Surveys
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.29.20248125
DO 10.1101/2021.01.29.20248125
A1 Garcia-Agundez, Augusto
A1 Ojo, Oluwasegun
A1 Hernandez, Harold
A1 Baquero, Carlos
A1 Frey, Davide
A1 Georgiou, Chryssis
A1 Goessens, Mathieu
A1 Lillo, Rosa
A1 Menezes, Raquel
A1 Nicolaou, Nicolas
A1 Ortega, Antonio
A1 Stavrakis, Efstathios
A1 Anta, Antonio Fernandez
YR 2021
UL http://medrxiv.org/content/early/2021/02/01/2021.01.29.20248125.abstract
AB During the initial phases of the COVID-19 pandemic, accurate tracking has proven unfeasible. Initial estimation methods pointed towards case numbers that were much higher than officially reported. In the CoronaSurveys project, we have been addressing this issue using open online surveys with indirect reporting. We compare our estimates with the results of a serology study for Spain, obtaining high correlations (R squared 0.89). In our view, these results strongly support the idea of using open surveys with indirect reporting as a method to broadly sense the progress of a pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAt the time of writing this article, CoronaSurveys has received no public funding. Social networks surveys have been partially funded via donations through our website. CoronaSurveys received an award from the UMD/CMU COVID-19 Symptom Data Challenge.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Coronasurveys was aproved by the ethics committee of the IMDEA Networks instituteAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are publicly available in the CoronaSurveys Github Repository https://github.com/GCGImdea/coronasurveys